Nanoform launches next-generation STARMAP® v2.0, the AI-based drug candidate selection tool for CESS® ...Middle East

HELSINKI, March 22, 2021 /PRNewswire/ -- Nanoform Finland Plc, an innovative nanoparticle medicine enabling company, has today launched the next generation of its STARMAP® AI (artificial intelligence) platform, v2.0. The technology utilizes sparse-data AI to augment experimental results...

Hence then, the article about nanoform launches next generation starmap v2 0 the ai based drug candidate selection tool for cess was published today ( Monday 22/03/2021 - 10:00 AM ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Nanoform launches next-generation STARMAP® v2.0, the AI-based drug candidate selection tool for CESS® )

Also on site :

• Trader Joe's $4 Find Has Returned — Why Fans Obsess Over the Easy Dinner
• Brewers Acquire Junior Fernández
• Amazon’s 'Buttery-Soft' $7 Long-Sleeve Shirt Is a 'Staple Piece' That Has Shoppers Running Back for More